Investor
The behavioral health-focused company will use the Series A funds to accelerate product development and expand support for its customer base.
The company offers an at-home test where a breath sample is collected and analyzed by trained dogs and AI to detect early-stage cancer.
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
The company's filing comes two months after fellow digital musculoskeletal care company Hinge Health filed for IPO.
Also, Lytus adds an AI-driven blood logistics platform to its health technology portfolio.
The funding comes on the heels of Carta Healthcare’s acquisition of Realyze Intelligence last year.
The announcement comes less than a year after Dexcom announced a strategic partnership and $75 million investment in the health-tracking ring maker.
It offers end-to-end, AI-driven digital ecosystem solutions for hospitals and insurers.
Epicore Biosystems expands Series B to $32 million to advance sweat-sensing wearable technology.
Aktiia announced an oversubscribed $42 million Series B round, and Basil Systems secured $11.5 million in funding.